Selective competitive phosphatidyl choline-specific phospholipase C (PC-PLC) inhibitor (Ki
= 6.4 μ
M); antiviral and antitumor agent. Suppresses LPS- and IFNγ
-induced NO production (IC50
= 20 mg/ml) and blocks oxidative glutamate toxicity in nerve cells. Antioxidant in vivo
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
The antiviral, antitumoural xanthate D609 is a competitive inhibitor of phosphatidylcholine-specific phospholipase C.
Drugs Exp.Clin.Res., 1996;22:287
Phosphatidylcholine-specific phospholipase C regulates glutamate-induced nerve cell death.
Li et al.
D609 inhibits ionizing radiation-induced oxidative damage by acting as a potent antioxidant.
Zhou et al.
Induction of nitric oxide synthase activity in phagocytic cells inhibited by tricyclodecan-9-yl-xanthogenate (D609).
Tschiakowsky et al.
The citations listed below are publications that use Tocris products. Selected citations for D609 include:
Showing Results 1 - 2 of 2